CYP2C19 Genotyping May Provide a Better Treatment Strategy when Administering Escitalopram in Chinese Population
Depression disorder is one of the most serious mental illnesses in the world. Escitalopram is the essential first-line medication for depression disorder. It is the substrate of hepatic cytochrome P450 (CYP) enzyme CYP2C19 with high polymorphism. The effect of CYP2C19 on pharmacokinetics and pharmac...
Main Authors: | Xinyi Huang, Chao Li, Chaopeng Li, Zhenyu Li, Xiaohui Li, Jianwei Liao, Tai Rao, Lulu Chen, Lichen Gao, Dongsheng Ouyang |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2021-08-01
|
Series: | Frontiers in Pharmacology |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fphar.2021.730461/full |
Similar Items
-
Effect of escitalopram on the processing of emotional faces
by: W.C. Alves-Neto, et al.
Published: (2010-03-01) -
Hypnic jerks possibly induced by escitalopram
by: Harshal Sathe, et al.
Published: (2015-03-01) -
Thrombocytopenia due to escitalopram use – A rare case report at the emergency department
by: Cihan Bedel, et al.
Published: (2021-01-01) -
Escitalopram-induced severe akathisia leading to suicide attempt
by: Alok Pratap, et al.
Published: (2019-01-01) -
Reversible Hemifacial Spasm after Starting Escitalopram
by: Mazen Abdulrahaman Basheikh
Published: (2020-03-01)